Systematic Financial Management LP Has $22.23 Million Stock Position in Azenta, Inc. (NASDAQ:AZTA)

Systematic Financial Management LP grew its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 2.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 444,521 shares of the company's stock after purchasing an additional 9,924 shares during the period. Systematic Financial Management LP owned about 0.97% of Azenta worth $22,226,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Ballentine Partners LLC lifted its holdings in Azenta by 2.0% during the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after purchasing an additional 404 shares during the last quarter. Boothbay Fund Management LLC increased its holdings in shares of Azenta by 8.4% during the fourth quarter. Boothbay Fund Management LLC now owns 6,571 shares of the company's stock worth $329,000 after buying an additional 509 shares in the last quarter. Picton Mahoney Asset Management raised its stake in shares of Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after acquiring an additional 532 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of Azenta by 14.9% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock worth $225,000 after acquiring an additional 576 shares in the last quarter. Finally, KBC Group NV grew its position in Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after acquiring an additional 698 shares during the last quarter. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Trading Up 4.2%

Shares of AZTA traded up $1.15 on Tuesday, reaching $28.27. 1,111,734 shares of the company's stock were exchanged, compared to its average volume of 681,663. The business has a 50 day moving average price of $29.62 and a two-hundred day moving average price of $41.35. Azenta, Inc. has a 12 month low of $23.91 and a 12 month high of $63.58. The stock has a market capitalization of $1.29 billion, a P/E ratio of -9.49 and a beta of 1.64.

Azenta (NASDAQ:AZTA - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. The company's revenue was up 5.1% on a year-over-year basis. During the same quarter last year, the business posted $0.06 EPS. Equities research analysts predict that Azenta, Inc. will post 0.53 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Evercore ISI lifted their price objective on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research report on Thursday, February 6th. Needham & Company LLC cut their price target on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th. Finally, TD Cowen upgraded shares of Azenta to a "hold" rating in a research report on Thursday, February 27th.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.